Telomere biology in heart failure

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
European Journal of Heart Failure (Impact Factor: 6.53). 10/2008; 10(11):1049-56. DOI: 10.1016/j.ejheart.2008.08.007
Source: PubMed


The incidence and prevalence of cardiovascular disease increases progressively with advancing age. Cardiovascular disease is a major cause of morbidity and mortality in Western Countries. In the near future, as the population ages, it is expected that the population prevalence of cardiovascular disease will increase dramatically, imposing a major social and economical burden on society. Not only is age closely related to the development and progression of cardiovascular disease, but genetic and environmental factors also play an important role. Recently, a chromosomal mechanism, telomere shortening, has been considered a driving force by which genetic and environmental factors jointly affect biological aging, and possibly the risk for developing age-associated diseases. Telomeres are the extreme ends of chromosomes and shorten progressively during every cell cycle and therefore can be considered an indicator of biological age. In heart failure, telomere length is severely reduced. In the current review, we will discuss the emerging role of telomere biology in the pathophysiology of heart failure.

Download full-text


Available from: Rudolf Allert de Boer, Jan 09, 2015
12 Reads
  • Source
    • "Telomeres are specialized DNA structures made up of tandem repeats (TTAGGG in humans) located at the end of chromosomes [4, 5]. Telomeres have a critical function as they serve as protective caps, preventing the chromosomal ends to be accidently recognized as DNA double strands by the DNA damage–repair system, and activation of the p53 or p16INK4a pathway, which eventually leads to senescence or apoptosis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: During normal aging, the heart undergoes functional, morphological and cellular changes. Although aging per se does not lead to the expression of heart failure, it is likely that age-associated changes lower the threshold for the manifestation of signs and symptoms of heart failure. In patients, the susceptibility, age of onset and pace of progression of heart failure are highly variable. The presence of conventional risk factors cannot completely explain this variability. Accumulation of DNA damage and telomere attrition results in an increase in cellular senescence and apoptosis, resulting in a decrease in the number and function of cells, contributing to the overall tissue and organ dysfunction. Biological aging, characterized by reduced telomere length, provides an explanation for the highly interindividual variable threshold to express the clinical syndrome of heart failure at some stage during life. In this review, we will elaborate on the current knowledge of aging of the heart, telomere biology and its potential role in the development of heart failure.
    Heart Failure Reviews 09/2010; 15(5):479-86. DOI:10.1007/s10741-010-9173-7 · 3.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Not Available
    Signals, Systems and Computers, 2005. Conference Record of the Thirty-Ninth Asilomar Conference on; 01/2005
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis and heart failure are major causes of morbidity and mortality in Western countries. Recent studies are suggesting involvement of telomere biology in the development and progression of age-associated conditions, including hypertension, atherosclerosis, and heart failure. Whether any of these reported associations are based on causal relationships remains to be elucidated. The construction of telomerase-deficient (telomerase RNA component, TERC(-/-)) mice might provide a potential instrumental model to study the involvement of telomere biology in cardiovascular disease. Here, we review the current available information from all studies performed in TERC(-/-) mice providing information on the cardiovascular phenotypic characteristics. Although this mouse model has proven its value in the understanding of the role of telomere biology in cancer, stem cell, and basic telomere research, only few studies were specifically designed to answer cardiovascular-related questions. The TERC(-/-) mice provide exciting opportunities to expand our knowledge of telomere biology in cardiovascular disease and the potential identification of novel targets of treatment.
    Cardiovascular Research 02/2009; 81(2):244-52. DOI:10.1093/cvr/cvn337 · 5.94 Impact Factor
Show more